Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Recruiting · NCT06858449 · Interventional (participants receive a specific treatment) · Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
View the official record on ClinicalTrials.gov →Interventions studied
Whey protein (20 grams)Whey protein (60 grams)
What this trial is about
In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.
Who can take part
Age range
20 Years to 89 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 20-89 years
- Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
- Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
- Must be able to read and understand English and consent for themselves.
Exclusion criteria
- Inability to get up and down off the ground or squat body weight
- Inability to safely engage in group exercise sessions as deemed by study PI
- Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
- Lactose intolerance
- Cow's milk or whey protein allergy
- Pregnant women
- Males
Where it is running
1 location listed across 1 US state.
- Allegheny General Hospital - Pittsburgh, Pennsylvania, United States